Dermal penetration enhancers and drug delivery systems...

Details Dermal penetration enhancers and drug delivery systems... Dermal penetration enhancers and drug delivery systems...

2004-01-20

2008-10-21

Richter, Johann (Department: 1616)

Dispensing

With discharge assistant

With discharge volume varying means

C424S448000, C424S449000

Reexamination Certificate

active

07438203

ABSTRACT:
The invention relates to a method for treatment or prophylaxis of a disease or condition in an animal comprising administering to a mucosal membrane of said animal in need of such treatment a therapeutically effective amount of a drug delivery system comprising at least one physiologically active agent or prodrug thereof and at least one penetration enhancer selected from safe ester sunscreens.

REFERENCES:
patent: 3306252 (1967-02-01), Knight et al.
patent: 3989816 (1976-11-01), Rajadhyaksha
patent: 4299826 (1981-11-01), Luedders
patent: 4310511 (1982-01-01), Holick
patent: 4440777 (1984-04-01), Zupan
patent: 4557934 (1985-12-01), Cooper
patent: 4563346 (1986-01-01), Deckner
patent: 4663157 (1987-05-01), Brock
patent: 4699779 (1987-10-01), Palinczar
patent: 4704406 (1987-11-01), Stanislaus et al.
patent: 4820724 (1989-04-01), Nimni
patent: 4938951 (1990-07-01), Leung et al.
patent: 4946671 (1990-08-01), Bissett et al.
patent: 4954487 (1990-09-01), Cooper et al.
patent: 4959205 (1990-09-01), Brunner et al.
patent: 4975272 (1990-12-01), Voyt
patent: 5030442 (1991-07-01), Uster et al.
patent: 5034386 (1991-07-01), Peck et al.
patent: 5036100 (1991-07-01), Deboeck et al.
patent: 5082866 (1992-01-01), Wong et al.
patent: 5100918 (1992-03-01), Sunshine et al.
patent: 5122519 (1992-06-01), Ritter
patent: 5192534 (1993-03-01), Grollier et al.
patent: 5256647 (1993-10-01), Minaskanian et al.
patent: 5413794 (1995-05-01), Suzuki et al.
patent: 5426210 (1995-06-01), Kato et al.
patent: 5446025 (1995-08-01), Lu et al.
patent: 5449519 (1995-09-01), Wolf et al.
patent: 5487898 (1996-01-01), Lu et al.
patent: 5573754 (1996-11-01), Kulkarni et al.
patent: 5674912 (1997-10-01), Martin
patent: 5679374 (1997-10-01), Fanchon et al.
patent: 5804168 (1998-09-01), Murad
patent: 5951967 (1999-09-01), Golz et al.
patent: 6004969 (1999-12-01), Hu
patent: 6010716 (2000-01-01), Saunal et al.
patent: 6211250 (2001-04-01), Tomlinson et al.
patent: 6299900 (2001-10-01), Reed et al.
patent: 6818226 (2004-11-01), Reed et al.
patent: 6916486 (2005-07-01), Klose et al.
patent: 6916487 (2005-07-01), Klose et al.
patent: 6923983 (2005-08-01), Morgan et al.
patent: 6929801 (2005-08-01), Klose et al.
patent: 2004/0096405 (2004-05-01), Chew et al.
patent: 2005/0186141 (2005-08-01), Gonda et al.
patent: 30258/89 (1989-09-01), None
patent: 49984/1990 (1989-09-01), None
patent: A-30258/89 (1989-09-01), None
patent: A-49984/90 (1990-09-01), None
patent: 91413/91 (1992-06-01), None
patent: 2 218 534 (1996-06-01), None
patent: 43 34 553 (1995-04-01), None
patent: 0 189 861 (1986-08-01), None
patent: 189 861 (1986-08-01), None
patent: 0 332 147 (1989-09-01), None
patent: 0 552 405 (1993-07-01), None
patent: 0 552 405 (1993-07-01), None
patent: 0 581 587 (1994-02-01), None
patent: 0 614 354 (1994-09-01), None
patent: 0608 322 (1998-07-01), None
patent: 61-268631 (1986-11-01), None
patent: WO 92/10154 (1992-06-01), None
patent: 92/19271 (1992-11-01), None
patent: WO 92/20376 (1992-11-01), None
patent: WO 93/10755 (1993-06-01), None
patent: WO 96/17624 (1996-06-01), None
patent: 96/30000 (1996-10-01), None
patent: WO 96/41613 (1996-12-01), None
R. J. Feldmann et al., “Percutaneous Penetration of 14C Hydrocortisone In Man”,Arch Derm, vol. 94:649-651, (1966).
M. F. Coldman et al., “Enhancement Of Percutaneous Absorption by The Use Of Volatile: Nonvolatile Systems And Vehicles”,Journal of Pharmaceutical Sciences, vol. 58(9):1098-1102, (1969).
P. P. Bhatt, et al., “Finite Dose Transport Of Drugs In Liquid Formulations Through Stratum Corneum: Analytical Solution To A Diffusion Model”,International Journal Of Pharmaceutics, Elsevier science Publishers B. V., vol. 50:197-203, (1989).
Nimni, U.S. Patent No. 4,820,742, Internet: www.patents.ibm.com/fegi-bin/any2htm Document “Dual phase Solvent Carrier System”, pp. 3, 4 and 6 out of 7 pages.
Bucks et al., Percutaneous Absorption of Hydroquinone in Humans: Effect of 1-Dodecylazacycloheptan-2-One (Azone) and the 2-Ethylhexyl Ester of 4-(Dimethylamino) Benzoic Acid (Escalol 507), Journal of Toxicology and Environmental Health, 24:279-289 (1988).
Physicians' Desk Reference (49 Ed.) 1995, .pp. 1151-1152, Medical Economics Company, Inc., Montvale, N.J.
Good et al., “A New Transdermal Delivery System for Estraiol,” Journal of Controlled Release 2:89-97 (1985) © Elsevier Science Publishers B.V., Amsterdam—Printed in The Netherlands.
Apr. 3, 2007 Office Action from related U.S. Appl. No. 11/513,342 (8 pgs.).
Office Action issued Jul. 11, 2007 in U.S. Appl. No. 11/517,575 (7 pgs.).

Affiliated with

Also associated with

Rating

Dermal penetration enhancers and drug delivery systems... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dermal penetration enhancers and drug delivery systems..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dermal penetration enhancers and drug delivery systems... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3994263